GLP-1 receptor agonist and SGLT2 inhibitor prescribing in people with type 1 diabetes
The receptor for GLP-1 is the GLP-1 receptor (GLP1R gene, below in the genotype report section), a G-protein-coupled receptor
GIP (Glucose-dependent insulinotropic polypeptide or gastric inhibitory polypeptide) is an intestinal hormone that acts on its receptor, GIP-R, to stimulate insulin secretion
Veroniki AA, Jackson D, Viechtbauer W et al (2016) Methods to estimate the between-study variance and its uncertainty in meta-analysis
"GOLO is life-changing and has made such a difference in my life
As previously reported, the reduction of inflammation may be related to weight loss, that was significant in the different outcome trials, going from a 0.6-kg reduction at 12 weeks with Lixisenatide in ELIXA trial to 4.3 kg at 2 years with injectable semaglutide in SUSTAIN-6 trial [25, 26]